Clinical trial
Single Centre Randomised Controlled Trial to Assess the Effect of the Addition of Twenty-four Hours of Oral Tranexamic Acid Post-operatively to a Single Intra-operative Intravenous Dose of Tranexamic Acid on Calculated Blood Loss Following Primary Hip and Knee Arthroplasty.
NCT03690037 is registered in ClinicalTrials.gov with Belfast Health and Social Care Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Centre Randomised Controlled Trial to Assess the Effect of the Addition of Twenty-four Hours of Oral Tranexamic Acid Post-operatively to a Single Intra-operative Intravenous Dose of Tranexamic Acid on Calculated Blood Loss Following Primary Hip and Knee Arthroplasty.
- Lead sponsor
- Belfast Health and Social Care Trust
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 7, 2016
- Completion date
- July 8, 2019
- Enrollment
- 1,089 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary total hip arthroplasty, primary total knee arthroplasty